Cardiodaron (amiodarone) tablets 0.2 g. №10

Description

Relapse prevention:
ventricular tachycardia, which poses a threat to the patient’s life: treatment should be started in a hospital setting with constant monitoring of the patient’s condition;
symptomatic ventricular tachycardia (documented) that results in disability;
supraventricular tachycardia (documented) in need of treatment, and in cases where other drugs have no therapeutic effect or are contraindicated;
ventricular fibrillation.
Treatment of supraventricular tachycardia: slowing or reducing atrial fibrillation or atrial flutter.
Coronary heart disease and / or left ventricular dysfunction (see Pharmacodynamics).